JPRN-UMIN000008165RecruitingPhase 2
Randomized phase II trial of adjuvant chemotherapy with vinorelbine plus cisplatin versus S-1 plus carboplatin in patients with completely resected stage II/IIIA non-small cell lung cancer - Adjuvant VNR+CDDP vs CBDCA+S-1 for Stage II/IIIA NSCLC
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Contraindication with S-1, carboplatin, vinorelbine and cisplatin 2) With large cell neuroendocrine carcinoma(LCNEC) 3) With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray 4) With double cancer, multiple cancer 5) With Serious post-operative complications 6) With severe drug allergies 7) With serious concurrent disease 8) With serious diarrhea 9) Current use of flucytosine 10) Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 11) Physician concludes that the patient's participation in this trial is inappropriate
Investigators
Similar Trials
Completed
Phase 2
Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000000781Japanese Northern East Area Thoracic Surgery Study Group120
Active, not recruiting
Phase 2
Randomized Phase II study of adjuvant chemotherapy with GC versus GS in patients with BTC undergoing curative resection without major hepatectomybiliary tract cancerBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-jRCTs051190040Yanagimoto Hiroaki106
Completed
Phase 2
Randomized Phase II study of adjuvant chemotherapy with gemcitabine plus cisplatin versus gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy(KHBO1901)biliary tract cancerJPRN-UMIN000036449Kansai Hepatobiliary Oncology Group (KHBO)106
Active, not recruiting
Not Applicable
Randomized phase II study of adjuvant chemotherapy with cisplatin + vinorelbine vs gemcitabine + vinorelbine in stage IB-IIIA radically resected non-small cell lung cancer (NSCLC) patients - MADSnon-small cell lung cancer (NSCLC)MedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2008-000570-21-ITIST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO
Not yet recruiting
Unknown
Randomized Phase 2 study of Adjuvant Chemotherapy vs Observation After Complete Resection of Stage III Soft Tissue SarcomasNeoplasmsKCT0008321ational Cancer Center98